North Carolina will get nearly $1.2 million from a $612 million settlement with pharmaceutical giant Amgen over fraudulent Medicaid claims, kickbacks and other misrepresentations.
As part of the settlement with federal prosecutors, the California drug company pleaded guilty Tuesday to a misdemeanor count of promoting an anemia drug for higher doses than it was approved.
The federal settlement ended an eight-year investigation based on 10 whistleblower cases filed in New York, Massachusetts and Washington state.
North Carolina's portion of the settlement was reached by the N.C. Attorney General's Medicaid Investigations Division and the N.C. Division of Medical Assistance.
